Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

This publication has 38 references indexed in Scilit:

• Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade Carcinomas
  Cancer Research, 2009
• Ovarian Cancer
  Annual Review Of Pathology-Mechanisms Of Disease, 2009
• Targeting the PI3K p110α Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration
  Clinical Cancer Research, 2008
• Effects of the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical Imaging
  Cancer Research, 2008
• Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study
  International Journal of Gynecologic Cancer, 2008
• Pathogenesis of Ovarian Cancer
  International Journal of Gynecological Pathology, 2008
• Ovarian clear cell adenocarcinoma: a continuing enigma: Table 1
  Journal of Clinical Pathology, 2006
• Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
  British Journal of Cancer, 2006
• Origins and molecular pathology of ovarian cancer
  Laboratory Investigation, 2005
• PIK3CA mutations in advanced ovarian carcinomas
  Human Mutation, 2005